Exciting news from #BioTechX! Our CEO, Chris Hackley, took the stage with PJ Brooks and Jeff Milton to talk about the future of genetic medicine and our mission of revolutionizing gene editing via long-range rewrites. Thanks @RareWaters for inviting us! #biotech#crispr
I am pleased to announce our pre-print detailing our novel long-range DNA editing technology is now live! We think our approach could have a dramatic impact on tackling the issue of genetic diversity in rare-disease.
Check it out here:
https://t.co/oYEYg8nxGH
CRISP-HR is thrilled to unveil groundbreaking research at ASGCT! We're showcasing our recent breakthrough in long-range editing, unlocking the potential to rewrite thousands of base pairs and treat previously incurable diseases! Visit us at poster #1167 #ASGCT2023#CRISPR
It was great having the whole team on-site @illumina Accelerator! The genomic data we're gathering through NGS constantly delivers new scientific insights, fueling our mission to discover and develop novel gene-based therapeutics for rare diseases.
#IlluminaProud#CRISPR#NGS
Great @ASGCTherapy workshop had many great presentations, including 3 speakers on 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐇𝐃𝐑 𝐠𝐞𝐧𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠 (pictured L to R)
Chris Hackley @CRISP_HR
Mollie Schubert @IDTdna
Sridhar Selvaraj @Stanford#𝘈𝘚𝘎𝘊𝘛22 http
Just saw that it is free to read @CRISPRjournal Top-Read Articles!
Excited to be on the SAB and see that @CRISP_HR have a paper in the top 5 most read articles:
https://t.co/hCpIE0xbdt
This week the @illumina Accelerator announced our investment in 7 startups working on groundbreaking genomic applications in therapeutics, diagnostics, DNA Storage, mental wellness, and sustainable foods. Congrats to the incoming class! They are...
https://t.co/mKJSVLmOvG
Looking for a new opportunity? We are a CRISPR-based biotech seeking a Research Associate to join our Therapeutic Discovery team starting in March/April 2022. Visit https://t.co/3ceEPnOFOy for more info! #hiring#jobs#biotech#crispr#startup
A warm welcome to our new Scientist, Chris Piggott, PhD! Chris has 6+ years experience in molecular and cell biology and will be helping transition us from R&D to therapeutic development using the Cas9-HR Platform!
We are pleased to welcome our new team members, Antonina and Jocelin, who will be assisting with the push forward towards therapeutic development using the Cas9-HR Platform.
#CRISPR#CRISPRCas#GenomeEditing#GeneTherapy#Cas9hr
An endangered species -- the solo-author paper!
"A Novel Set of Cas9 Fusion Proteins to Stimulate Homologous Recombination: Cas9-HRs" --
Chris Hackley @CRISP_HR
https://t.co/v2fRKA2vv5
CRISP-HR is hiring! We are looking for a Scientist and Technicians. If you have a biological background and are interested in joining a biotech startup, take a look at our careers page at https://t.co/3ceEPnOFOy. #hiring#careers#startup#biotech
We are excited to announce that we're relocating to a new facility, @MBiolabs – a premier biotech incubator in the Bay Area with state of the art equipment. A great place to finish the Cas9-HR Platform and start therapeutic discovery! #biotech#startup